Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4141 to 4155 of 8926 results

  1. Diabetes: ACEi or ARBs (IND134)

    This indicator covers the percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM95.

    General practice indicators suitable for use in QOF
    Last updated
    28 June 2022

  2. Kidney conditions: CKD and SGLT2 inhibitors (IND324)

    This indicator covers the percentage of patients on the CKD register who are treated with an SGLT-2 inhibitor if they have: type 2 diabetes, or no type 2 diabetes and an eGFR 20 ml/min/1.73 m2 to 44 ml/min/1.73 m2 and are currently treated with an ACE inhibitor or angiotensin receptor blocker (ARB) (unless these are contraindicated) or an eGFR 45 ml/min/1.73 m2 to 59 ml/min/1.73 m2, are currently treated with an ACE inhibitor or ARB (unless these are contraindicated) and have a urine albumin-to-creatinine ratio (ACR) of 22.6 mg/mmol or more. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.

    General practice indicators suitable for use in QOF
    Published
    18 February 2026

  3. Published

    The complete list of all our published indicators, for measuring outcomes that reflect the quality of care or processes, linked by evidence to improved outcomes.

  4. Subscribe to our GP reference panel

    Subscribe to our GP reference panel and contribute to the development of NICE guidance in a quick and easy way.

  5. Key question: effective

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  6. Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implant (HTG732)

    Evidence-based recommendations on direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implant. This involves inserting a metal implant through the skin and into the centre of the bone of the stump and attaching a prosthetic limb to it.

    HealthTech guidance
    Published
    17 December 2024
    View recommendations

    Sections for HTG732

  7. Resource planner

    Our resource planner tool to help you plan for and implement NICE guidance.

  8. Further information about MTAC registration and meetings

    More detail about Medical Technologies Advisory Committee (MTAC) registration, meeting arrangements and types of attendee.

  9. Quality standards advisory committee members

    Read biographies of the members of our quality standards advisory committee.

  10. Technology appraisal committee A members

    Biographies and registered interests for members of the Technology Appraisal Committee A

  11. Antimicrobials evaluation panel

    Details and meeting dates of the antimicrobials evaluation panel

  12. Medical technologies advisory committee members

    Read the biographies of our medical technologies advisory committee members.

  13. Further information about IPAC registration and meetings

    More detail about Interventional Procedures Advisory Committee (IPAC) registration, meeting arrangements and types of attendee.

  14. Further information about DAC registration and meetings

    More detail about Diagnostics Advisory Committee (DAC) registration, meeting arrangements and types of attendee.

  15. Important information on how to register

    Home Get involved Our committees NICE committee meetings...